Benefit-Risk Assessment in Pharmaceutical Research and Development - Chapman & Hall / CRC Biostatistics Series - - Books - Taylor & Francis Ltd - 9780367576240 - June 30, 2020
In case cover and title do not match, the title is correct

Benefit-Risk Assessment in Pharmaceutical Research and Development - Chapman & Hall / CRC Biostatistics Series 1st edition

Price
HK$ 620
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 31 - Aug 12

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D, from early clinical development to late-stage development to regulatory review to post-launch assessment. Suitable for those in b

220 pages

Media Books     Paperback Book   (Book with soft cover and glued back)
Released June 30, 2020
ISBN13 9780367576240
Publishers Taylor & Francis Ltd
Pages 220
Dimensions 150 × 220 × 10 mm   ·   410 g
Language English  
Editor Felli, James
Editor Noel, Rebecca
Editor Sashegyi, Andreas

More from the same publisher